atovaquone has been researched along with Retinoblastoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, W; Ke, F; Li, X; Liao, Y; Si, X; Yang, F; Yu, J; Zuo, Z | 1 |
1 other study(ies) available for atovaquone and Retinoblastoma
Article | Year |
---|---|
The anti-malarial atovaquone selectively increases chemosensitivity in retinoblastoma via mitochondrial dysfunction-dependent oxidative damage and Akt/AMPK/mTOR inhibition.
Topics: AMP-Activated Protein Kinases; Antimalarials; Antineoplastic Agents; Atovaquone; Cell Line, Tumor; Cell Movement; Cell Proliferation; DNA Damage; Glycolysis; Humans; Mitochondria; Oxidative Stress; Oxygen; Proto-Oncogene Proteins c-akt; Retina; Retinoblastoma; Signal Transduction; TOR Serine-Threonine Kinases | 2018 |